[2-year data of large clinical comparative studies. Type 2 diabetes: lasting metabolic control with pioglitazone].
D000818:Animals; D002986:Clinical Trials as Topic; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism; D004359:Drug Therapy, Combination; D005907:Gliclazide / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007333:Insulin Resistance; D008687:Metformin / Q000008:administration & dosage / Q000627:therapeutic use; D051379:Mice; D000077205:Pioglitazone; D045162:Thiazolidinediones / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D008687:Metformin; D005907:Gliclazide; D000077205:Pioglitazone